We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients (TBIDU)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01290081
First Posted: February 4, 2011
Last Update Posted: February 4, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
Information provided by:
National Institute for Health Development, Estonia
  Purpose
The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Condition Intervention
Tuberculosis Other: Case management approach in referral to health care services

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

Resource links provided by NLM:


Further study details as provided by National Institute for Health Development, Estonia:

Enrollment: 112
Study Start Date: October 2007
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Active referral
Case management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
No Intervention: Passive referral
Participants were instructed to schedule an appointment with TB services themselves.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Participation in substitution treatment program,
  • Age 18 years or more,
  • Able to read and write in Estonian or Russian,
  • Able to provide informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01290081


Locations
Estonia
LLC Corrigo
Jõhvi, Ida-Virumaa, Estonia, 41532
Sponsors and Collaborators
National Institute for Health Development, Estonia
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kristi Rüütel, National Institute for Health Development
ClinicalTrials.gov Identifier: NCT01290081     History of Changes
Other Study ID Numbers: TBIDU-1230
First Submitted: February 3, 2011
First Posted: February 4, 2011
Last Update Posted: February 4, 2011
Last Verified: January 2008

Keywords provided by National Institute for Health Development, Estonia:
Tuberculosis
Injecting drug users
Case management

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections